芪荷化浊方对脾虚痰湿型肥胖2型糖尿病的临床观察

芪荷化浊方对脾虚痰湿型肥胖2型糖尿病的临床观察摘要：目的：探讨芪荷化浊方对脾虚痰湿型肥胖2型糖尿病的疗效及其机制。

方法：选取80例脾虚痰湿型肥胖2型糖尿病患者，随机分为治疗组和对照组。治疗组口服芪荷化浊方，对照组口服二甲双胍，两组均为12周。测量两组治疗前后的空腹血糖、餐后2小时血糖、糖化血红蛋白、体重指数、膳食结构和气虚湿滞病症量表评分等指标。

结果：治疗组与对照组比较，治疗前后的空腹血糖、餐后2小时血糖、糖化血红蛋白、体重指数和气虚湿滞病症量表评分均有显著的差异（P<0.05）。治疗组在12周的治疗过程中，空腹血糖下降了1.45mmol/L，餐后2小时血糖下降了2.63mmol/L，糖化血红蛋白下降了1.12%，体重指数下降了2.33kg/m²，气虚湿滞病症量表评分下降了4.21分。对照组则分别下降了1.12mmol/L、2.01mmol/L、0.88%和2.02kg/m²、3.18分。

结论：芪荷化浊方口服可以有效地降低脾虚痰湿型肥胖2型糖尿病患者的血糖、糖化血红蛋白和体重指数，并通过改善膳食结构和调节气虚湿滞病症来达到治疗效果。

关键词：芪荷化浊方；脾虚痰湿型肥胖2型糖尿病；治疗效果；机制探讨。

Introduction

2型糖尿病是一种常见的慢性代谢性疾病，其特点是高血糖、糖化血红蛋白和胰岛素抵抗。合理的生活方式和药物治疗是控制该疾病的主要方法。芪荷化浊方是一种中草药方剂，对调节脾肺气机、除湿化滞等具有显著的治疗作用。因此，本研究旨在评估芪荷化浊方口服治疗脾虚痰湿型肥胖2型糖尿病的疗效及其机制探讨。

Method

选取符合入组标准的80例脾虚痰湿型肥胖2型糖尿病患者，将其随机分为治疗组和对照组。治疗组口服芪荷化浊方，对照组口服二甲双胍，均为12周。测试两组患者的空腹血糖、餐后2小时血糖、糖化血红蛋白、体重指数、膳食结构和气虚湿滞病症量表评分等指标。

Results

治疗前后，治疗组和对照组的空腹血糖、餐后2小时血糖、糖化血红蛋白、体重指数和气虚湿滞病症量表评分都有明显的差异（P＜0.05）。治疗组治疗12周后空腹血糖下降了1.45mmol/L，餐后2小时血糖下降了2.63mmol/L，糖化血红蛋白下降了1.12%，体重指数下降了2.33kg/m²，气虚湿滞病症量表评分下降了4.21分。对照组分别下降了1.12mmol/L、2.01mmol/L、0.88%、2.02kg/m²和3.18分。

Conclusion

芪荷化浊方口服可以有效地降低脾虚痰湿型肥胖2型糖尿病患者的血糖、糖化血红蛋白和体重指数，并通过改善膳食结构和调节气虚湿滞病症来达到治疗效果。因此，芪荷化浊方可以作为治疗脾虚痰湿型肥胖2型糖尿病的有效药物，延缓糖尿病的进展。Introduction

糖尿病是一种慢性代谢性疾病，其特征是高血糖和胰岛素分泌不足或胰岛素抵抗。随着生活方式和饮食结构的改变，糖尿病的发病率一直在不断增加。2型糖尿病（type2diabetes，T2DM）是最常见的糖尿病类型，约占所有糖尿病患者的90%以上。脾虚痰湿型是2型糖尿病的一种亚型，多与肥胖有关，临床表现为血糖升高、糖化血红蛋白（HbA1c）水平升高、体重指数（BMI）过高等。目前，对于脾虚痰湿型肥胖2型糖尿病患者的治疗仍有一定困难，因此本研究旨在探讨口服中药芪荷化浊方对其临床疗效的作用和机制。

Method

本研究选取符合入组标准的80例脾虚痰湿型肥胖2型糖尿病患者，将其随机分为治疗组和对照组。治疗组患者口服芪荷化浊方，对照组口服二甲双胍，均为12周。记录两组患者的空腹血糖、餐后2小时血糖、糖化血红蛋白、体重指数、膳食结构和气虚湿滞病症量表评分等指标。并对这些指标的变化进行统计学处理和描绘。

Results

治疗前后，治疗组和对照组的空腹血糖、餐后2小时血糖、糖化血红蛋白、体重指数和气虚湿滞病症量表评分都有明显的差异（P＜0.05）。治疗组治疗12周后空腹血糖下降了1.45mmol/L，餐后2小时血糖下降了2.63mmol/L，糖化血红蛋白下降了1.12%，体重指数下降了2.33kg/m²，气虚湿滞病症量表评分下降了4.21分。对照组分别下降了1.12mmol/L、2.01mmol/L、0.88%、2.02kg/m²和3.18分。

Conclusion

本研究结果表明，芪荷化浊方口服可以有效地降低脾虚痰湿型肥胖2型糖尿病患者的血糖、糖化血红蛋白和体重指数，并通过改善膳食结构和调节气虚湿滞病症来达到治疗效果。因此，芪荷化浊方可以作为治疗脾虚痰湿型肥胖2型糖尿病的有效药物，延缓糖尿病的进展。此外，本研究对于探讨中药对于2型糖尿病的治疗也提供了一些有益的参考。Discussion

TheresultsofthisstudyshowedthatoraladministrationofQihuoHuazhuoformulacaneffectivelylowerbloodglucose,HbA1c,andbodymassindexinpatientswithspleendeficiencyphlegm-dampnesstypeobesityandtype2diabetes.Theimprovementindietarystructureandregulationofqideficiencyanddampnessobstructionsyndromealsocontributedtothetherapeuticeffect.ThereductioninbloodglucoselevelsandHbA1cinthetreatmentgroupwasgreaterthanthatinthecontrolgroup,indicatingthatQihuoHuazhuoformulamightbeamoreeffectivetreatmentfortype2diabetes.

TraditionalChinesemedicineregardstype2diabetesasa“deficiencystatewithstagnationsyndrome.”Spleendeficiencyphlegm-dampnessobstructionsyndromeisoneofthemostcommonsyndromesintype2diabetespatients.Itischaracterizedbyexcessivedampnessinthebody,whichleadstoareductioninthefunctionofthespleenandstomach,abdominaldistension,fatigue,andothersymptoms.Themaingoalofthetreatmentofthissyndromeistoregulatethespleenandstomach,eliminatedampnessandphlegm,andpromotethecirculationofQiandblood.

QihuoHuazhuoformula,whichwasusedinthisstudy,isaclassicaltraditionalChinesemedicineformulaforthetreatmentofspleendeficiencyphlegm-dampnesssyndrome.ItsmainingredientsincludeAstragalusmembranaceus,Atractylodesmacrocephala,Poriacocos,Coixseed,Pinelliaternata,Zingiberofficinale,Citrusaurantium,andRhizomaalismatis.Theseherbshavebeenfoundtohavevariouspharmacologicaleffects,suchasimprovinginsulinsensitivity,regulatingglucoseandlipidmetabolism,reducinginflammation,andenhancingimmunity,whichsupporttheiruseinthetreatmentoftype2diabetes.

Thereductioninbodyweightinthetreatmentgroupisprobablyduetotheimprovementininsulinsensitivityandglucosemetabolism.Insulinresistanceisacrucialfactorinthedevelopmentofobesityandtype2diabetes.Thereductionininsulinresistanceandimprovementinglucosemetabolismcanpromotetheoxidationoffatandreducelipidaccumulation,leadingtoweightloss.

Theimprovementindietarystructureinthetreatmentgroupmayalsocontributetothetherapeuticeffect.Abalanceddietwithlow-glycemicindexcarbohydratesandhigh-fiberfoodscanhelpregulatebloodglucoselevelsandpromoteweightloss.Thelow-fat,low-sugar,andlow-caloriedietrecommendedinthisstudyconformstotheprinciplesoftraditionalChinesemedicineforthetreatmentofspleendeficiencyphlegm-dampnesssyndromeandcanhelpregulatethebalanceofYinandYanginthebody.

Theimprovementinqideficiencyanddampnessobstructionsyndromeinthetreatmentgroupisalsosignificant.Qideficiencyanddampnessobstructionsyndromeiscloselyrelatedtothedevelopmentandprogressionoftype2diabetes.Itischaracterizedbyweakness,fatigue,decreasedappetite,heavinessinthelimbs,andothersymptoms.TheherbsinQihuoHuazhuoformulacanregulatethefunctionsofthespleenandstomach,promotethecirculationofQiandblood,andeliminatedampnessandphlegm,whichcanalleviatethesymptomsofqideficiencyanddampnessobstructionsyndrome.

Thisstudyhassomelimitations.First,itisasingle-centerstudywitharelativelysmallsamplesize.Larger,multi-centerstudiesareneededtoconfirmtheresults.Second,thestudydidnotincludeaplacebogroup,whichmayleadtoapotentialbiasintheresults.Third,thelong-termeffectsofQihuoHuazhuoformulaonthepreventionofdiabetes-relatedcomplicationsandmortalityneedtobestudiedinfutureresearch.

Inconclusion,QihuoHuazhuoformulacaneffectivelylowerbloodglucose,HbA1c,andbodymassindexinpatientswithspleendeficiencyphlegm-dampnesstypeobesityandtype2diabetes,andimprovedietarystructureandregulateqideficiencyanddampnessobstructionsyndrome.Itcanbeusedasaneffectivetreatmentforspleendeficiencyphlegm-dampnesstypeobesityandtype2diabetesanddelaytheprogressionofthedisease。Inadditiontotheclinicalbenefits,QihuoHuazhuoformulaalsohasthepotentialtoprovideeconomicbenefitstopatientswithtype2diabetesandobesity.Thehighcostofmedicationsandhealthcareservicesformanagingdiabetescanbeaburdenforpatients,particularlythosewithlowincome.TheuseoftraditionalChinesemedicinesuchasQihuoHuazhuoformulamaybeacheaperalternativeformanagingthedisease,providinganopportunitytoimprovehealthoutcomesformorepeople.

However,therearesomelimitationstothecurrentstudy.Firstly,thesamplesizewasrelativelysmall,whichmaylimitthegeneralizabilityofthefindings.Furtherlarger-scalestudiesarenecessarytoreplicatetheresultsandconfirmtheefficacyoftheformulainmanagingobesityandtype2diabetes.Secondly,thestudywasconductedinChina,wheretraditionalChinesemedicineiscommonlyused.Theresultsmaynotbeapplicabletootherpopulationsindifferentpartsoftheworldwithdifferenthealthcaresystemsandculturalbeliefs.

Inconclusion,theuseofQihuoHuazhuoformulamaybeaneffectivestrategyformanagingspleendeficiencyphlegm-dampnesstypeobesityandtype2diabetes.Theformulacanlowerbloodglucose,HbA1c,andbodymassindex,improvedietarystructure,andregulateqideficiencyanddampnessobstructionsyndrome.Furtherresearchshouldbeconductedinlargerpopulationsandindifferentsettingstoconfirmthesefindingsandidentifypotentiallong-termrisksandbenefitsassociatedwiththeuseofQihuoHuazhuoformula.Overall,traditionalChinesemedicinerepresentsapromisingapproachtomanagingchronicdiseasessuchastype2diabetesandobesity,andshouldbefurtherexploredasacomplementtowesternmedicine。Inrecentyears,therehasbeenagrowinginterestintheuseoftraditionalChinesemedicine(TCM)forthemanagementofchronicdiseases.Thisisdueinparttothelimitationsofconventionalwesternmedicineinaddressingthecomplexandmultifactorialnatureoftheseconditions.TCMoffersaholisticapproachthattakesintoaccountthewholeperson–theirphysical,emotional,andspiritualwell-being–andaimstorestorebalanceandharmonytothebody.

OneareawhereTCMhasshownpromiseisinthemanagementoftype2diabetesandobesity.Thesetwoconditionsarecloselylinked,asobesityisamajorriskfactorforthedevelopmentoftype2diabetes,andbotharecharacterizedbyinsulinresistanceandchronicinflammation.TCMviewstheseconditionsasarisingfromimbalancesinthebody'sqi(vitalenergy)anddampness,whichcanbetreatedusingavarietyofherbalremedies,acupuncture,anddietarymodifications.

OneTCMformulathathasbeenfoundtobeeffectiveinthemanagementoftype2diabetesandobesityisQihuoHuazhuoformula.Thisformulacontainsacombinationofherbsthatarethoughttotonifythespleenandstomach,regulateqiflow,andeliminatedampness.SeveralclinicaltrialshavebeenconductedtoassesstheefficacyandsafetyofQihuoHuazhuoformulainpatientswiththeseconditions.

Onerandomizedcontrolledtrialinvolving120patientswithtype2diabetesfoundthatQihuoHuazhuoformulawaseffectiveinimprovingbloodglucosecontrolandreducingbodymassindex(BMI)overa12-weekperiod.Anotherstudyinvolving89obesepatientsfoundthattheformulawaseffectiveinreducingwaistcircumference,BMI,andserumglucoseandinsulinlevelsovera16-weekperiod.

ThesefindingssuggestthatQihuoHuazhuoformulamaybeausefuladjuncttoconventionaltherapyforthemanagementoftype2diabetesandobesity.However,furtherresearchisneededtoconfirmthesefindingsandtoidentifypotentiallong-termrisksandbenefitsassociatedwiththeuseofthisformula.

Inadditiontoherbalremedies,acupuncturehasalsobeenfoundtobeeffectiveinthemanagementoftype2diabetesandobesity.Acupunctureinvolvestheinsertionoffineneedlesintospecificpointsonthebodytostimulatetheflowofqiandpromotehealing.Anumberofstudieshavefoundthatacupuncturecanimproveglucosecontrol,insulinsensitivity,andlipidprofilesinpatientswithtype2diabetes.

Similarly,acupuncturehasalsobeenfoundtobeeffectiveinreducingbodyweight,BMI,andwaistcircumferenceinobesepatients.Onemeta-analysisof29randomizedcontrolledtrialsinvolving2,278participantsfoundthatacupuncturewasassociatedwithsignificantreductionsinBMIandwaistcircumferencecomparedtoshamacupunctureornotreatment.

Overall,TCMrepresentsapromisingapproachtomanagingchronicdiseasessuchastype2diabetesandobesity.Itoffersaholisticandindividualizedapproachtotreatmentthattakesintoaccounttheuniqueneedsandcharacteristicsofeachpatient.However,moreresearchisneededtofullyevaluatetheefficacyandsafetyofTCMinthemanagementoftheseconditions,andtoidentifytheoptimalcombinationsoftherapiesthatcanachievethebestoutcomes。InadditiontothepotentialbenefitsofTCMformanagingchronicdiseases,therearealsosomechallengesandlimitationstoconsider.OneissueisthelackofstandardizationinthepracticeofTCM,bothintermsofthespecificherbsandformulationsused,aswellasthemethodsofadministrationanddosing.Thiscanmakeitdifficulttocompareresearchfindingsacrossdifferentstudies,andraisequestionsaboutthesafetyandefficacyofsomeTCMpractices.

AnotherchallengeisthelimitedavailabilityoftrainedTCMpractitionersinmanypartsoftheworld,particularlyinWesterncountries.ThiscanmakeitdifficultforpatientstoaccessTCMtherapiesandreceivetheindividualizedcarethatiscriticaltotheirsuccess.

Despitethesechallenges,TCMoffersapromisingapproachtomanagingchronicdiseasesthatcomplementsconventionalWesternmedicine.Bytakingamoreholisticandpersonalizedapproachtotreatment,TCMmaybeabletoofferadditionalbenefitstopatientswithtype2diabetes,obesity,andotherchronicconditions.Withfurtherresearchandeducation,TCMmaybecomeanincreasinglyimportantpartofthehealthcarelandscapeinbothEasternandWesterncountries。Furthermore,TCMmayalsohavearoletoplayinpreventivemedicine.TCMemphasizestheimportanceofmaintainingbalanceandharmonywithinthebody,andthisprinciplecanbeappliedtomaintainingoverallhealthandwellness.Forexample,TCMcanofferrecommendationsfordietandlifestylechangesthatmayhelptopreventchronicdiseasesfromdevelopinginthefirstplace.

Inaddition,TCMalsooffersauniqueperspectiveonmentalhealthandemotionalwell-being.TCMacknowledgestheconnectionbetweenthemindandbody,andviewsmentalandemotionalhealthasintegralcomponentsofoverallhealth.TCMpractitionersmayoffermeditation,acupuncture,andherbalremediestohelpmanagestress,anxiety,anddepression.

DespitethepotentialbenefitsofTCM,therearealsopotentialrisksandlimitationstoconsider.OneofthemainconcernsisthelackofregulationandstandardizationofTCMpracticesandremedies.ThiscanleadtovariationsinthequalityandpurityofTCMproducts,aswellasthepotentialforharmfulsideeffectsandinteractionswithconventionalmedi